Cargando…
Gene Ontology (GO)-Driven Inference of Candidate Proteomic Markers Associated with Muscle Atrophy Conditions
Skeletal muscle homeostasis is essential for the maintenance of a healthy and active lifestyle. Imbalance in muscle homeostasis has significant consequences such as atrophy, loss of muscle mass, and progressive loss of functions. Aging-related muscle wasting, sarcopenia, and atrophy as a consequence...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9457532/ https://www.ncbi.nlm.nih.gov/pubmed/36080280 http://dx.doi.org/10.3390/molecules27175514 |
_version_ | 1784786078561992704 |
---|---|
author | Stalmach, Angelique Boehm, Ines Fernandes, Marco Rutter, Alison Skipworth, Richard J. E. Husi, Holger |
author_facet | Stalmach, Angelique Boehm, Ines Fernandes, Marco Rutter, Alison Skipworth, Richard J. E. Husi, Holger |
author_sort | Stalmach, Angelique |
collection | PubMed |
description | Skeletal muscle homeostasis is essential for the maintenance of a healthy and active lifestyle. Imbalance in muscle homeostasis has significant consequences such as atrophy, loss of muscle mass, and progressive loss of functions. Aging-related muscle wasting, sarcopenia, and atrophy as a consequence of disease, such as cachexia, reduce the quality of life, increase morbidity and result in an overall poor prognosis. Investigating the muscle proteome related to muscle atrophy diseases has a great potential for diagnostic medicine to identify (i) potential protein biomarkers, and (ii) biological processes and functions common or unique to muscle wasting, cachexia, sarcopenia, and aging alone. We conducted a meta-analysis using gene ontology (GO) analysis of 24 human proteomic studies using tissue samples (skeletal muscle and adipose biopsies) and/or biofluids (serum, plasma, urine). Whilst there were few similarities in protein directionality across studies, biological processes common to conditions were identified. Here we demonstrate that the GO analysis of published human proteomics data can identify processes not revealed by single studies. We recommend the integration of proteomics data from tissue samples and biofluids to yield a comprehensive overview of the human skeletal muscle proteome. This will facilitate the identification of biomarkers and potential pathways of muscle-wasting conditions for use in clinics. |
format | Online Article Text |
id | pubmed-9457532 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-94575322022-09-09 Gene Ontology (GO)-Driven Inference of Candidate Proteomic Markers Associated with Muscle Atrophy Conditions Stalmach, Angelique Boehm, Ines Fernandes, Marco Rutter, Alison Skipworth, Richard J. E. Husi, Holger Molecules Article Skeletal muscle homeostasis is essential for the maintenance of a healthy and active lifestyle. Imbalance in muscle homeostasis has significant consequences such as atrophy, loss of muscle mass, and progressive loss of functions. Aging-related muscle wasting, sarcopenia, and atrophy as a consequence of disease, such as cachexia, reduce the quality of life, increase morbidity and result in an overall poor prognosis. Investigating the muscle proteome related to muscle atrophy diseases has a great potential for diagnostic medicine to identify (i) potential protein biomarkers, and (ii) biological processes and functions common or unique to muscle wasting, cachexia, sarcopenia, and aging alone. We conducted a meta-analysis using gene ontology (GO) analysis of 24 human proteomic studies using tissue samples (skeletal muscle and adipose biopsies) and/or biofluids (serum, plasma, urine). Whilst there were few similarities in protein directionality across studies, biological processes common to conditions were identified. Here we demonstrate that the GO analysis of published human proteomics data can identify processes not revealed by single studies. We recommend the integration of proteomics data from tissue samples and biofluids to yield a comprehensive overview of the human skeletal muscle proteome. This will facilitate the identification of biomarkers and potential pathways of muscle-wasting conditions for use in clinics. MDPI 2022-08-27 /pmc/articles/PMC9457532/ /pubmed/36080280 http://dx.doi.org/10.3390/molecules27175514 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Stalmach, Angelique Boehm, Ines Fernandes, Marco Rutter, Alison Skipworth, Richard J. E. Husi, Holger Gene Ontology (GO)-Driven Inference of Candidate Proteomic Markers Associated with Muscle Atrophy Conditions |
title | Gene Ontology (GO)-Driven Inference of Candidate Proteomic Markers Associated with Muscle Atrophy Conditions |
title_full | Gene Ontology (GO)-Driven Inference of Candidate Proteomic Markers Associated with Muscle Atrophy Conditions |
title_fullStr | Gene Ontology (GO)-Driven Inference of Candidate Proteomic Markers Associated with Muscle Atrophy Conditions |
title_full_unstemmed | Gene Ontology (GO)-Driven Inference of Candidate Proteomic Markers Associated with Muscle Atrophy Conditions |
title_short | Gene Ontology (GO)-Driven Inference of Candidate Proteomic Markers Associated with Muscle Atrophy Conditions |
title_sort | gene ontology (go)-driven inference of candidate proteomic markers associated with muscle atrophy conditions |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9457532/ https://www.ncbi.nlm.nih.gov/pubmed/36080280 http://dx.doi.org/10.3390/molecules27175514 |
work_keys_str_mv | AT stalmachangelique geneontologygodriveninferenceofcandidateproteomicmarkersassociatedwithmuscleatrophyconditions AT boehmines geneontologygodriveninferenceofcandidateproteomicmarkersassociatedwithmuscleatrophyconditions AT fernandesmarco geneontologygodriveninferenceofcandidateproteomicmarkersassociatedwithmuscleatrophyconditions AT rutteralison geneontologygodriveninferenceofcandidateproteomicmarkersassociatedwithmuscleatrophyconditions AT skipworthrichardje geneontologygodriveninferenceofcandidateproteomicmarkersassociatedwithmuscleatrophyconditions AT husiholger geneontologygodriveninferenceofcandidateproteomicmarkersassociatedwithmuscleatrophyconditions |